Primary Record
acarbose
- In stock
- 1,291 g
- Purity
- 99.3 %
- CAS
- 56180-94-0
Compound Identifiers & Properties
- CAS
- 56180-94-0
- PubChem CID
- 444254
- SMILES
- C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)O)O)CO)CO)O)O)N[C@H]4C=C([C@H]([C@@H]([C@H]4O)O)O)CO
- Canonical SMILES
- C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O
Names & Synonyms
- acarbose
- Precose
- Glucobay
- Prandase
- Acarbosa
- Acarbosum
- Glucor
- Alpha-Acarbose
- Arcabose
- Ascarbose
- Beta-Acarbose
- Glucobay;
- Precose;
- Amylostatin J;
- (S)-amisulpride
- 1agm
- 1ukt
- Glucobay (TN)
- Prandase (TN)
- BAY-g 5421
- Precose (TN)
- Acarbosum [INN-Latin]
- Acarbosa [INN-Spanish]
- Bay-g-5421
- Acarbose, >=95%
- RefChem:934711
- Bay g 5421
- GlyTouCan:G08743RW
- D0AD5C
- D0QU8H
- AC1L9G0J
- CHEMBL1566
- UNII-T58MSI464G
- SCHEMBL16848
- Acarbose (JAN/USAN/INN)
- Acarbose [USAN:BAN:INN:JAN]
- XUFXOAAUWZOOIT-SXARVLRPSA-N
- BAYG5421
- GTPL6791
- DTXCID6026034
- DTXSID8046034
- CHEBI:94035
- HSDB 7984
- 56180-94-0
- Acarbose [USAN:INN:BAN:JAN]
- BCPP000442
- C25H43NO18
- HMS3269L19
- HMS3413P19
- HMS3677P19
- HMS3713B18
- G08743RW
- EINECS 260-030-7
- Tox21_111597
- BDBM50333465
- CID444254
- EBC-46065
- s1271
- ZINC85537042
- Acarbose [USAN:USP:INN:BAN:JAN]
- AKOS024457233
- C25-H43-N-O18
- Tox21_111597_1
- BCP9000224
- CCG-220568
- Prandase;Precose;Glucobay;Bay-g 5421
- NCGC00159353-02
- NCGC00160515-02
- AB2000022
- CAS-56180-94-0
- ACI-(1-4)GLD-(1-4)GLC-(1-4)GLB
- FT-0621713
- FT-0776097
- HMC-(1-4)AGL-(1-4)GLC-(1-4)GLC
- NS00001516
- droxymethyl)tetrahydro-2H-pyran-2,3,4-triol
- J1.629.106D
- AB01274765-01
- AB01274765_02
- EN300-27025603
- Q338005
- Prandase, Precose, Glucobay, Bay-g 5421, Acarbose
- BRD-K44276885-001-01-7
- BRD-K44276885-001-05-8
- BRD-K44276885-001-07-4
- Acarbose, European Pharmacopoeia (EP) Reference Standard
- xy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6-(hy
- (2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol
- Acarbose, United States Pharmacopeia (USP) Reference Standard
- (2R,3R,4R,5R,6R)-5-((2R,3R,4R,5S,6R)-5-((2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-enylamino)-tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyran-2,3,4-triol
- (2R,3R,4R,5S,6R)-5-{[(2R,3R,4R,5S,6R)-5-{[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl)oxane-2,3,4-triol
- Acarbose for identification, European Pharmacopoeia (EP) Reference Standard
- Acarbose, Pharmaceutical Secondary Standard; Certified Reference Material
- 1,4-DEOXY-4-((5-HYDROXYMETHYL-2,3,4-TRIHYDROXYCYCLOHEX-5,6-ENYL)AMINO)FRUCTOSE
- Acarbose for peak identification, European Pharmacopoeia (EP) Reference Standard
- (2R,3R,4R,5S,6R)-5-(((2R,3R,4R,5S,6R)-5-(((2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)tetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydro
- (2R,3R,4R,5S,6R)-5-((2R,3R,4R,5S,6R)-5-((2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-enylamino)-tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyran-2,3,4-triol
- (2R,3R,4R,5S,6R)-5-((2R,3R,4R,5S,6R)-5-((2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-((1S,4S,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-enylamino)-tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyran-2,3,4-triol
- (2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol
- (3R,4R,5S,6R)-5-((2R,3R,4R,5S,6R)-5-((2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-enylamino)-tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyran-2,3,4-triol
- 4,6-Dideoxy-4-([1S]-[1,4,6/5]-4,5,6-trihydroxy-3-hydroxymethyl-2-yclohexenylamino)maltotriose
- 4-O-[4-O-[4-[[(1S,4R,5S,6S)-4,5,6-Trihydroxy-3-hydroxymethyl-2-cyclohexene-1-yl]amino]-4,6-dideoxy-alpha-D-glucopyranosyl]-alpha-D-glucopyranosyl]-beta-D-glucopyranose
- 4?,6?-dideoxy-4?-[(1S)-(1,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2-cyclohexenylamino]maltotriose
- 5-{5-[3,4-Dihydroxy-6-methyl-5-(4,5,6-trihydroxy-3-hydroxymethyl-cyclohex-2-enylamino)-tetrahydro-pyran-2-yloxy]-3,4-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy}-6-hydroxymethyl-tetrahydro-pyran-2,3,4-triol
- 71675-92-8
- ACR
- D-glucosa, o-4,6-dideoxi-4-[[(1s,4r,5s,6s)-4,5,6-trihidroxi-3-(hidroximetil)-2-ciclohexen-1-il]amino]-?-d-glucopiranosil-(1?4)-o-?-d-glucopiranosil-(1?4)-
- D-Glucose, O-4,6-dideoxy-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-.alpha.-D-glucopyranosyl-(1->4)-O-.alpha.-D-glucopyranosyl-(1->4)-
- O-4,6-Dideoxy-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-alpha-D-glucopyranosyl-(1->4)-O-alpha-D-glucopyranosyl-(1->4)-D-glucose
- O-4,6-Dideoxy-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-?-D-glucopyranosyl-(1-4)-O-?-D-glucopyranosyl-(1-4)-D-Glucose